- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05199987
Breathing Control Exercises in Patients With Chronic Obstructive Pulmonary Disease.
Impact of Occupational Therapy With Breathing Control Exercises in Patients With Chronic Obstructive Pulmonary Disease.
Study Overview
Status
Conditions
Detailed Description
Dyspnea is one of the most important and debilitating symptoms in patients with COPD and is often the starting point to the vicious cycle of physical inactivity. As a consequence of increased dyspnea, patients adapt themselves by reducing the amount of all activities of daily living performed, with a consequent reduction in quality of life.
Occupational therapists are involved in pulmonary rehabilitation programs aiming to improve the biopsychosocial condition of COPD patients. However, the specific roles and intervention of occupational therapists are not well-defined, and standardized protocols are lacking. The implementation of breathing control exercises in occupational therapy sessions, aiming among other things to regulate patient's breathing during their activities of daily living, could be a starting point for a more effective management of patients with COPD. This could ultimately participate in the improvement of quality of life in patients with COPD.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Anderlecht, Belgium, 1070
- J Bracops Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Confirmed diagnostic of COPD
- Severity of COPD: global initiative for chronic obstructive lung disease (GOLD) classification III or IV
- Undergoing a pulmonary rehabilitation program in J. Bracops Hospital
Exclusion Criteria:
- Cardiac or orthopedic complications limiting participation in occupational therapy sessions
- Active smoking
- Inability to understand the French language orally or in writing
- Cognitive impairments limiting understanding of instructions and participation in occupational therapy sessions
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Standard Occupational Therapy
This group will receive standard occupational therapy sessions
|
Standard occupational therapy sessions include patient therapeutic education (implementation of strategies and/or technical aids promoting autonomy and independence), walking and stair exercises in real-life conditions (weighted shopping bag, unstable ground, ...), as well as work on activities of daily living aiming to improve toileting skills (includes individual assessment, the use of technical aids depending of this assessment, and personalised strategies to conserve energy).
|
Experimental: Occupational Therapy with Breathing Control Exercises
This group will receive the same component of the control group + breathing control exercises
|
Includes the same treatment than the one described in standard occupation therapy but with the addition of 30-minute sessions per day on breathing control exercises.
These exercises included the reproduction of gestures reproducing daily activities and simultaneous explanations of breathing techniques that the patient can perform in order to set up strategies for saving breath during exercise.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in St George's Respiratory Questionnaire score
Time Frame: At baseline and after 6 weeks of pulmonary rehabilitation
|
Overall health, daily life, and perceived well-being are assessed via the St George's Respiratory Questionnaire and its three domains: "symptoms", "activities" and "impact". The score for each domain and the total score ranged from 0 to 100, with 100 indicating a very poor quality of life. |
At baseline and after 6 weeks of pulmonary rehabilitation
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in health-related quality of life
Time Frame: At baseline and after 6 weeks of pulmonary rehabilitation
|
Health-related quality of life is assessed via the CAT (COPD assessment test) score.
The assessment consists of eight questions, with a score associated with each question ranging from 0 to 5, with 0 indicating no impact on quality of life.
The total score ranges from 0 to 40.
The higher the score, the greater the impact on quality of life.
|
At baseline and after 6 weeks of pulmonary rehabilitation
|
Change in dyspnea
Time Frame: At rest and after the effort, at baseline as well as after 6 weeks of pulmonary rehabilitation
|
Dyspnea is rated with a visual analogic scale (0 to 100mm).
|
At rest and after the effort, at baseline as well as after 6 weeks of pulmonary rehabilitation
|
Change in hand grip strength
Time Frame: At baseline and after 6 weeks of pulmonary rehabilitation
|
Hand grip strength test is assessed via a hand dynamometer (JAMAR).
The best value of three repetitions of the best hand is reported.
|
At baseline and after 6 weeks of pulmonary rehabilitation
|
Change in functional capacity
Time Frame: At baseline and after 6 weeks of pulmonary rehabilitation
|
Functional capacity is assessed with the five-time sit-to-stand test.
The time the individual takes to sit down and stand up completely over five repetitions is reported
|
At baseline and after 6 weeks of pulmonary rehabilitation
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- ErgoControl
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Severe Chronic Obstructive Pulmonary Disease
-
Spire, Inc.ResMedCompletedSevere Chronic Obstructive Pulmonary Disease | Moderate Chronic Obstructive Pulmonary DiseaseUnited States
-
Hopital FochAir Liquide SARecruitingChronic Obstructive Pulmonary Disease SevereFrance
-
University Hospital, ToursCompletedSevere Chronic Obstructive Pulmonary DiseaseFrance
-
Hospital de MataróCompleted
-
Schön Klinik Berchtesgadener LandResMedCompletedChronic Obstructive Pulmonary Disease SevereGermany
-
Randall DebattistaUniversity of Malta, Faculty of Health SciencesNot yet recruitingChronic Obstructive Pulmonary Disease Moderate | Acute Exacerbation of COPD | Chronic Obstructive Pulmonary Disease Severe
-
Taipei Medical UniversityUnknownChronic Obstructive Pulmonary Disease Severe | Chronic Obstructive Pulmonary Disease End StageTaiwan
-
Karaganda Medical UniversityCompletedChronic Obstructive Pulmonary Disease | Chronic Obstructive Pulmonary Disease Moderate | Chronic Obstructive Pulmonary Disease SevereKazakhstan
-
AstraZenecaMedImmune LLCCompletedModerate to Very Severe Chronic Obstructive Pulmonary DiseaseUnited States, Denmark, France, Sweden, Thailand, Vietnam, Belgium, Brazil, Peru, Philippines, Turkey, Taiwan, Argentina, Australia, Israel, Poland, Ukraine, Slovenia, Serbia, Mexico, Bulgaria, Colombia, New Zealand, Chile, Norway, Croatia
-
AstraZenecaMedImmune LLCCompletedModerate to Very Severe Chronic Obstructive Pulmonary DiseaseUnited States, Canada, Germany, Italy, Netherlands, Spain, United Kingdom, Poland, Japan, Austria, Korea, Republic of, Russian Federation, South Africa, Czechia, Hungary, Romania, Switzerland
Clinical Trials on Standard Occupational Therapy
-
The University of Texas Health Science Center,...Recruiting
-
Hacettepe UniversityAuthorsCompleted
-
Children's Hospital Medical Center, CincinnatiCompletedAutism Spectrum Disorder | Attention Deficit Hyperactivity DisorderUnited States
-
St. John's Rehab HospitalSunnybrook Health Sciences Centre; Washington University School of Medicine; University...CompletedStrokeUnited States, Canada
-
University of HaifaCompleted
-
Transilvania University of BrasovSpitalul Clinic de Psihiatrie si Neurologie BrasovSuspendedStroke SequelaeRomania
-
Nuffield Orthopaedic Centre NHS TrustOxford Brookes UniversityCompletedStroke | Multiple Sclerosis | Brain InjuryUnited Kingdom
-
University of ChileComisión Nacional de Investigación Científica y Tecnológica; Hospital de San...CompletedPostoperative Delirium | Aging DisorderChile
-
Institut GuttmannUniversity of Vic - Central University of CataloniaRecruitingAcquired Brain Injury | Mental Health IssueSpain
-
University of WashingtonTerminatedBreast Cancer | Breast Cancer Stage I | Breast Cancer Stage II | Breast Cancer Stage III | Breast Cancer Stage IIB | Breast Cancer Stage IIA | Breast Cancer Stage IIIA | Breast Cancer Stage IIIB | Breast Cancer Stage IIIcUnited States